Ending the Silent Epidemic of
Avoidable Amputations.
Every 30 seconds, a limb is lost to diabetes somewhere in the world. ZegeneX was founded on the conviction that geography, accessibility, and cold-chain logistics should never dictate whether a patient walks again.
Over 85% of lower-limb amputations worldwide begin with a seemingly minor foot ulcer that stalled in the natural biological healing cascade.
Major diabetic limb loss carries a 5-year mortality rate higher than colon cancer, breast cancer, or prostate cancer.
Due to prohibitive costs ($5k–$15k) and complex cold-chain storage, 94% of US DFU patients never receive advanced cellular or tissue therapy.
A new mechanism
for healing wounds
Zegenex cream helps restore the skin's natural healing process by blocking key growth factor inhibitors, allowing the body's own repair signals to work effectively.
Zegenex cream heals by blocking Growth Factor inhibitors
In a healthy wound
Growth factors like EGF, PDGF, FGF, and VEGF signal on schedule, driving fibroblast growth, cellular proliferation, and timely healing.
In a diabetic wound
Inhibitors block these same factors, stalling repair. ZGX5 binds and neutralizes those inhibitors, restoring the growth factors' signaling and the wound's natural healing cascade.
One solution. Many wounds.
Zegen-X5 delivers a single, potent regenerative solution across diverse acute, chronic, and traumatic wound scenarios.
Diabetic Foot Ulcers
Restores microvascular blood supply and triggers rapid cellular proliferation to close stalled chronic wounds.
Resolution of Burn Scars & Cosmetics
Accelerates deep epidermal regeneration, prevents fibrotic hypertrophic scarring, and restores natural skin aesthetics.
Lacerations & Acute Cuts
Closes surgical incisions and acute traumatic tears with high tensile strength and minimal scar margins.
Sports Injury & Athletics
Fast-tracks recovery from high-impact sports trauma, severe turf burns, joint abrasions, and track friction wounds.
Pet Wounds & Veterinary
Non-cytotoxic, lick-safe formulation for canine, feline, and equine trauma, hot spots, and post-surgical incisions.
Combat & Space Force
Mission-critical wound therapy for forward tactical battlefield triage and microgravity aerospace missions.
Accelerating Recovery Across the Sports Industry
From professional athletic leagues and collegiate sports to high-performance training, ZegeneX technology empowers sports medicine teams to treat acute trauma, cuts, and turf burns rapidly—minimizing downtime and returning athletes to the game faster.
High-Tensile Dermal Recovery for Peak Athletic Performance
Restores full skin barrier integrity and elasticity over joint and friction areas, preventing reinjury during high-impact movement.
Turf Burns & Friction Abrasions
Artificial turf and track friction cause painful, weeping abrasions that disrupt training. ZegeneX accelerates rapid re-epithelialization to stop weeping and restore smooth epidermal layers within days.
High-Stress Joint & Impact Lacerations
Cuts over knees, elbows, and knuckles experience continuous tension. ZegeneX promotes organized collagen alignment, providing the tensile resilience necessary to withstand flexion without split reopening.
Sideline Medical Kit & Locker Room Ready
Engineered for ambient stability (proven 9+ months at room temperature), ZegeneX requires zero refrigeration. Team trainers can carry it directly in travel bags for instant sideline application.
Scar Minimization & Preserved Range of Motion
Prevents rigid fibrotic scar formation that can restrict muscular motion and joint flexibility, preserving peak athletic performance and aesthetic skin healing.
Accelerated closure of acute turf abrasions and lacerations
Stays stable in trainer bags without cold storage
Reinforces skin elasticity across high-movement joints
Bridging the Deep Healthcare Access Divide
In premier urban medical centers across high-income countries, patients with non-healing diabetic foot ulcers occasionally access specialized multi-disciplinary wound centers equipped with hyperbaric oxygen chambers, cryopreserved living skin substitutes, and negative-pressure wound therapy.
Yet for the vast majority of the 589 million adults living with diabetes globally today (projected to reach 853 million by 2050 per the IDF Diabetes Atlas 11th Edition), such infrastructure simply does not exist. In rural communities, community health centers, veterans' clinics, and developing nations, biologic therapies spoil in transit because local facilities lack continuous sub-zero refrigeration.
Universal Access to Advanced Regenerative Medicine
By encapsulating biologic-level regenerative potency into an ambient-stable (25°C, 9+ months proven stability) synthetic small-molecule topical, Zegen-X5 can be stocked in neighborhood pharmacies, mailed directly to patient homes, and administered simply by nurses, caregivers, or patients themselves.